Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Novartis AG ADR (NYSE: NVS) closed at $131.19 in the last session, up 0.14% from day before closing price of $131.01. In other words, the price has increased by $0.14 from its previous closing price. On the day, 2.07 million shares were traded. NVS stock price reached its highest trading level at $131.63 during the session, while it also had its lowest trading level at $130.46.
Ratios:
We take a closer look at NVS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 25.52 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 12.65. For the most recent quarter (mrq), Quick Ratio is recorded 0.68 and its Current Ratio is at 0.88. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.55.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 23 ’25 when Marshall Fiona bought 15,000 shares for $112.68 per share.
Kowalski Robert William bought 1,212 shares of NVS for $137,297 on Apr 30 ’25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVS now has a Market Capitalization of 251726331904 and an Enterprise Value of 274502336512. As of this moment, Novartis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.89, and their Forward P/E ratio for the next fiscal year is 14.35. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.82. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.57 while its Price-to-Book (P/B) ratio in mrq is 5.68. Its current Enterprise Value per Revenue stands at 4.869 whereas that against EBITDA is 11.014.
Stock Price History:
The Beta on a monthly basis for NVS is 0.51, which has changed by 0.32883656 over the last 52 weeks, in comparison to a change of 0.13042927 over the same period for the S&P500. Over the past 52 weeks, NVS has reached a high of $134.24, while it has fallen to a 52-week low of $96.06. The 50-Day Moving Average of the stock is 1.39%, while the 200-Day Moving Average is calculated to be 9.61%.
Shares Statistics:
According to the various share statistics, NVS traded on average about 1.64M shares per day over the past 3-months and 1728740 shares per day over the past 10 days. A total of 1.92B shares are outstanding, with a floating share count of 1.90B. Insiders hold about 0.01% of the company’s shares, while institutions hold 7.15% stake in the company. Shares short for NVS as of 1764288000 were 4976663 with a Short Ratio of 3.04, compared to 1761868800 on 5749914. Therefore, it implies a Short% of Shares Outstanding of 4976663 and a Short% of Float of 0.26.
Dividends & Splits
The forward annual dividend rate for NVS is 3.87, which was 3.862 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.029478667. The stock’s 5-year Average Dividend Yield is 3.6. The current Payout Ratio is 55.42% for NVS, which recently paid a dividend on 2025-03-12 with an ex-dividend date of 2025-03-12. Stock splits for the company last occurred on 2019-04-09 when the company split stock in a 1116:1000 ratio.
Earnings Estimates
Current recommendations for the stock of the company come from 2.0 analysts.
Analysts are recommending an EPS of between $9.3 and $8.67 for the fiscal current year, implying an average EPS of $8.93. EPS for the following year is $9.22, with 7.0 analysts recommending between $9.38 and $8.94.
Revenue Estimates
According to 5 analysts,. The current quarter’s revenue is expected to be $13.64B. It ranges from a high estimate of $13.74B to a low estimate of $13.6B. As of. The current estimate, Novartis AG ADR’s year-ago sales were $13.15BFor the next quarter, 5 analysts are estimating revenue of $13.6B. There is a high estimate of $13.6B for the next quarter, whereas the lowest estimate is $13.6B.
A total of 16 analysts have provided revenue estimates for NVS’s current fiscal year. The highest revenue estimate was $57.35B, while the lowest revenue estimate was $54.4B, resulting in an average revenue estimate of $55.38B. In the same quarter a year ago, actual revenue was $50.32BBased on 12 analysts’ estimates, the company’s revenue will be $56.64B in the next fiscal year. The high estimate is $58.31B and the low estimate is $54.19B.
